Imperva Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Imperva are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Imperva has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Imperva is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Fifty Two Week Low | 55.71 | |
| Fifty Two Week High | 55.75 |
Imperva |
Imperva Relative Risk vs. Return Landscape
If you would invest (100.00) in Imperva on January 19, 2024 and sell it today you would earn a total of 100.00 from holding Imperva or generate -100.0% return on investment over 90 days. Imperva is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Imperva, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Imperva Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Imperva's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Imperva, and traders can use it to determine the average amount a Imperva's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IMPV |
Based on monthly moving average Imperva is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Imperva by adding Imperva to a well-diversified portfolio.
Imperva Fundamentals Growth
Imperva Stock prices reflect investors' perceptions of the future prospects and financial health of Imperva, and Imperva fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Imperva Stock performance.
| Return On Equity | 0.0812 | |||
| Return On Asset | 0.0474 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | (2.24) % | |||
| Current Valuation | 1.65 B | |||
| Shares Outstanding | 35.44 M | |||
| Price To Earning | 73.13 X | |||
| Price To Book | 5.74 X | |||
| Price To Sales | 5.62 X | |||
| Revenue | 351.76 M | |||
| EBITDA | 4.96 M | |||
| Cash And Equivalents | 304.42 M | |||
| Cash Per Share | 8.65 X | |||
| Total Debt | 621.95 K | |||
| Debt To Equity | 0.36 % | |||
| Book Value Per Share | 6.88 X | |||
| Cash Flow From Operations | 86.27 M | |||
| Earnings Per Share | (0.81) X | |||
| Total Asset | 397.67 M | |||
| Retained Earnings | (326.72 M) | |||
| Current Asset | 334.72 M | |||
| Current Liabilities | 120.54 M |
Things to note about Imperva performance evaluation
Checking the ongoing alerts about Imperva for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Imperva help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Imperva is not yet fully synchronised with the market data | |
| Imperva has some characteristics of a very speculative penny stock | |
| Imperva has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 351.76 M. Net Loss for the year was (28.14 M) with profit before overhead, payroll, taxes, and interest of 257.76 M. | |
| Over 99.0% of the company shares are owned by institutional investors |
- Analyzing Imperva's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Imperva's stock is overvalued or undervalued compared to its peers.
- Examining Imperva's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Imperva's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Imperva's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Imperva's stock. These opinions can provide insight into Imperva's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Imperva Stock
If you are still planning to invest in Imperva check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Imperva's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |